COVID-19
PRODUCT SEARCH
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
NPRA mission
NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
Columvi® (Glofitamab): New Important Identified Risk of Haemophagocytic Lymphohistiocytosis |
Directives & Circulars (GCP & GLP) |
Guidelines related to GCP & GLP |
Frequently Asked Questions (FAQ) e-labelling |
|
|
| 04 Sep 2025; 08:00AM - 05:00PM Bengkel Pengujian Kawalan Kualiti Bahan Mentah Herba Bagi Produk Semulajadi |







































